Research ArticleCancer

Irreversible inhibition of cytosolic thioredoxin reductase 1 as a mechanistic basis for anticancer therapy

See allHide authors and affiliations

Science Translational Medicine  14 Feb 2018:
Vol. 10, Issue 428, eaaf7444
DOI: 10.1126/scitranslmed.aaf7444
PDF Container

Navigate This Article